Search

Displaying 1 - 10 of 57

According to the National Highway Traffic Safety Administration1, distracted driving caused 3,522 people to lose their lives in 2021. What is distracted driving and how can you stay safe on the road? Read on to learn more. 

What is distracted driving?

Distracted driving is any movement that redirects attention away from the fundamental task of driving. The number one cause of motor vehicle...

(April 14, 2022, AUSTIN, TX) —The main results of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) trial, a National Heart, Lung, and Blood Institute (NHLBI) sponsored trial were presented. Although the results of the trial are not final, they offer valuable information for patients using the generic drug Spironolactone. This drug therapy activates white cells and...

New legislation could help improve the lives of kidney patients nationwide

Sept. 29, 2021, New York, NY — Today, new bipartisan legislation that seeks to make home dialysis more accessible and affordable to kidney patients was introduced in the House of Representatives by Bobby L. Rush (D-IL) and Jason Smith (R-MO).  The National Kidney Foundation (NKF) and its patient advocates have been working closely with champions in...

Living Donors Save Lives and Give Others a Second Chance at Life

May 13, 2021, New York, NY – While COVID-19 continues to dominate the United States healthcare system, nearly 100,000 Americans are still on a waitlist for a kidney transplant and each day 12 patients die waiting for a kidney. National Kidney Foundation (NKF) Health Policy...

A Scientific Workshop Co-Sponsored by the National Kidney Foundation and the US Food and Drug Administration

April 1, 2020, New York, NY — Emerging evidence supports the use of alternative endpoints to demonstrate the efficacy of treatments for progression of chronic kidney diseases.  Most notably in March 2018, the National Kidney Foundation (NKF), in collaboration with the US Food and Drug Administration (FDA) and the...

Initiative Marks New Phase of the NKF “Are You the 33%?” National Kidney Disease Awareness Campaign

Whippany, N.J., – (BUSINESS WIRE) – February 4, 2021 – Bayer and the National Kidney Foundation (NKF) today announced that award-winning actress, Debbie Allen, has joined the “Are You the 33%?” national public awareness campaign to focus attention on the increased risk of developing chronic kidney disease (CKD), also referred to as...

2020 is the perfect time to hear our call. One voice and one vision to heal and save lives.

National Minority Donor Awareness Month is a collaborative effort by the National Organ, Eye and Tissue Donation Multicultural Action Group to save and improve the quality of life of diverse communities by creating a positive culture for organ, eye, and tissue donation. National Minority Donor Awareness Month stems from National Minority...

Investigators present work at the National Kidney Foundation’s virtual Spring Clinicals Meetings   March 25, 2020, New York, NY—Today, the National Kidney Foundation (NKF) showcased a global study designed to understand the experimental immunosuppressant drug Voclosporin as a treatment for patients with lupus kidney disease.    The important study, ...
Organizations collaborate for National Kidney Month to raise awareness about the deadly disease   March 4, 2020, New York, NY – The National Kidney Foundation (NKF) and CVS Kidney Care, a CVS Health company, are partnering on a national campaign to raise awareness about kidney disease which affects approximately 37 million...
  Update from the Centers for Disease Control and Prevention still shows most with CKD don’t know they have it   New York, NY – July 17, 2019 – The number of American adults who have chronic kidney disease (CKD) is now estimated to be 37 million – that’s one out of every seven or 15 percent of the adult population – according to ...